CCES 2019 CCES vs Graeme Thompson
May 29, 2020
In September 2019 the Canadian Centre for Ethics in Sport (CCES) reported an anti-doping rule violation against the Athlete Graeme Thompson after his sample tested positive for the prohibited substances Clenbuterol and Tamoxifen. After notification the Athlete admitted the violation, waived his right for a hearing, accepted the provisional suspension and the sanction proposed by CCES.
The Athlete denied the intentional use of the substances and asserted that the positive test was the result of contaminated supplements he had used. Analysis of his supplements in the Montreal Lab confirmed the that they were contaminated. On 29 May 2020 the CCES decided to impose a 2 year period of ineligibility on the Athlete starting on the date of the provisional suspension, i.e. on 10 October 2019.
Previously in September 2019 the Athlete requested for a SDRCC Doping Tribunal hearing in order to lift the provisional suspension because the positive test was the result of a contaminated product he had used. The CCES contended that the Athlete failed to establish that contamination was likely to have been the cause of the anti-doping rule violation.
Considering the evidence and testimonies in the hearing the Arbitrator concluded that the anti-doping rule violation is likely the result of a contaminated product.
Therefore the SDRCC Doping Tribunal decided on 3 October 2019 that the CCES must lift the provisional suspension imposed on the Athlete.